2018-2023 Mitomycin C Market Research: Global Industry Analysis and Forecast

36
3433

In this report, LP Information covers the current scenario (base year being 2017) and growth prospects of the global mitomycin C market for 2018-2023.

Mitomycin C Market, Mitomycin C is an antibiotic that acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by reductive activation either by low pH or by NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

Over the past few years, the global mitomycin C market has witnessed a rapid upward trend, with an average growth rate of 4.76%. In 2016, the worldwide turnover of mitomycin C was nearly 119.83 M USD; the actual production is around 17370 K Unit.

The global average price of mitomycin C is in the upward trend from 6.30 USD/unit in 2012 to 6.90 USD/unit in 2016. With the situation of the global economy, the prices will be in a upward trend over the next five years.

The classification of Mitomycin C includes 2mg, 10mg, 40mg and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is decreasing from 2012 to 2016.

Mitomycin C is widely used in cancer treatment, ophthalmic use and other fields. The largest proportion of mitomycin C is cancer treatment, and the proportion in 2016 is 69%. The trend of cancer treatment is downward.

Japan is the largest supplier of Mitomycin C, with a production market share of nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying a production market share of nearly 25% in 2016.

North America is the first place of consumption, with a market share of nearly 36% in 2016. After North America, Europe is the second place of consumption with a market share of 32.6 %.

Over the next five years, LPI (LP Information) forecasts that Mitomycin C will register a -2.3% CAGR in revenue, reach US$100 million by 2023, from US$120 million in 2017 .

This report presents a comprehensive overview, market shares and growth opportunities of Mitomycin C market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers the value and volume generated from the sales of the following segments:

Segmentation by product type:

2mg

10mg

40mg

Other

Segmentation by applications:

Cancer treatment

Ophthalmic use

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

South East Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Inquire here and check the discount for the report @:

https://www.reporthive.com/enquiry.php?id=1565680&req_type=disc

The report also presents the competitive landscape of the market and a corresponding detailed analysis of the major vendors/manufacturers of the market. Key manufacturers covered in this report:

Kyowa Kirin

Intas Pharmaceuticals

Suits you

Bristol Myers Squibb

aspen

European Pharma specialty

Alkem Laboratories

Varifarma

APOGEPHA

In addition, this report examines the key drivers influencing market growth, the opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes major emerging trends and their impact on current and future development.

Research objectives:

To study and analyze the global Mitomycin C consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Mitomycin C market by identifying its various subsegments.

Focuses on the key global Mitomycin C manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans at course of the next few years.

To analyze the Mitomycin C with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information on key factors influencing market growth (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Mitomycin C submarkets, with respect to key regions (along with their respective key countries).

· To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

· Establish a strategic profile of key players and analyze in depth their growth strategies.

Read the full [email protected] research report: https://www.reporthive.com/enquiry.php?id=1565680&req_type=purch

Contents:

Chapter One: Report Scope

Chapter Two: Executive Summary

Chapter Three: Global Mitomycin C by Players

Chapter Four: Mitomycin C by Regions

Chapter Five: Americas

Chapter Six: APAC

Chapter Seven: Europe

Chapter Eight: Middle East and Africa

Chapter Nine: Market Drivers, Challenges and Trends

Chapter Ten: Marketing, Distributors and Customer

Read more…

List of tables and figures:

Figure Mitomycin C consumed in the treatment of cancer

Figure Global Mitomycin C: Cancer Treatment Market (2013-2018) (K Units)

Figure Global Mitomycin C: Cancer Treatment Market (2013-2018) (Million $)

Figure Annual Growth in Cancer Treatment Worldwide (Million $)

Figure Mitomycin C consumed in ophthalmic use

Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (K Units)

Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (Million $)

Figure Global Ophthalmic Use YoY Growth ($million) and more…



Source by Mike Ross

Comments are closed.